Oxford BioDynamics (GB:OBD) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Oxford BioDynamics has issued over 2.28 million shares to its directors and senior staff as a part of their salaries, preserving cash resources amid its strategic goals. This move aligns with the company’s focus on leveraging its EpiSwitch® 3D genomics platform for precision diagnostics. The shares will soon be admitted to trading on AIM, increasing the total share capital to over 314 million.
For further insights into GB:OBD stock, check out TipRanks’ Stock Analysis page.
